Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada · Delayed Price · Currency is CAD 9.62
+0.25 (2.67%)
Nov 3, 2026, 3:43 PM EST
Eupraxia Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Eupraxia Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $16.33. The average 1-year stock price forecast is 69.75% higher than the current stock price, while the lowest is $14.00 (+45.53%) and the highest is $18.00 (+87.11%).
Price Target: $16.33 (+69.75%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Eupraxia Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 11 | 11 | 11 | 12 | 12 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 11 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $15.42 | Buy | Reiterates | $15.42 | +60.29% | Oct 20, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $26.63 | Buy | Maintains | $26.63 | +176.86% | Oct 7, 2026 |
| Wedbush | Wedbush | Buy Maintains $23.83 | Buy | Maintains | $23.83 | +147.72% | Oct 1, 2026 |
| Bloom Burton | Bloom Burton | Buy Maintains $19.63 | Buy | Maintains | $19.63 | +104.00% | Oct 1, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $22.43 | Buy | Maintains | $22.43 | +133.15% | Sep 30, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
507.50K
EPS This Year
-0.99
from -1.00
EPS Next Year
-1.05
from -0.99
EPS and Forward PE are based on non-GAAP adjusted numbers.